Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia (AML) have found that a type of ...

Cytopenia at myelofibrosis diagnosis raises risk of acute myeloid leukemia and lowers survival, highlighting the need for ...

A new study by Indiana University School of Medicine researchers has revealed a breakthrough in the fight against acute ...

Acute myeloid leukaemia (AML) starts when the DNA and genes in the stem cells of the bone marrow undergo change known as genetic mutation. This leads to uncontrolled growth and proliferation of ...

"CAR T drives acute myeloid leukemia into submission in pre-clinical studies." ScienceDaily. ScienceDaily, 28 April 2022. <www.sciencedaily.com / releases / 2022 / 04 / 220428125358.htm>.

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for decitabine/cedazuridine plus venetoclax to treat adults with newly diagnosed acute myeloid leukemia ...

Researchers conducted a retrospective study published in July 2025 issue of Journal of Hematology & Oncology to examine the ...

Relapsed acute myeloid leukemia (AML) is when cancer returns after a period of remission. Refractory AML means cancer has not responded to multiple rounds of treatment. Both can affect your ...

Researchers at Tisch Cancer Center have created innovative models of acute myeloid leukemia, offering an unprecedented resource for studying this deadly blood cancer, according to a study ...

Childhood acute myeloid leukemia is a type of cancer that affects blood cells in the bone marrow. Learn more about this condition, including symptoms, how it’s diagnosed, treatments, and more.

Acute myeloid leukemia (AML) is the most common acute leukemia in adults, with an incidence of over 20 000 cases per year in the United States alone. Large chromosomal translocations as well as ...